Switzerland· 68282001
Ezetimib-Atorvastatin-Mepha
A atorvastatin and ezetimibe product containing ezetimibum, atorvastatinum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Atorvastatin and ezetimibe is registered in 10 of 19 countries.
Countries holding a registration under ATC C10BA05 (atorvastatin and ezetimibe), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
Atorvastatin and ezetimibe · ATC C10BA05
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- ezetimibum, atorvastatinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- C10BA05
- ATC class
- Atorvastatin and ezetimibe
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680682820016Blist 30 StkCHF 38
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for atorvastatin and ezetimibe.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atorvastatin and ezetimibe · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Atorvastatin and ezetimibe in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMEDO PLUSMedochemie Bohemia, spol. s r.o., Praha
- SpainATORDUO 10 MG/10 MG CAPSULAS DURASProterapia Hungary Kft.
- NetherlandsAtozet 10 mg/10 mg, filmomhulde tablettenN.V. Organon (Kloosterstraat 6)
- ItalyANCILLEGSANDOZ S.P.A.
- FranceEZETIMIBE/ATORVASTATINE ARROW 10 mg/10 mg, comprimé pelliculéARROW GENERIQUES
- IrelandAtozet 10 mg/10 mg film-coated tabletsOrganon Pharma (Ireland) Limited
- PolandAtozetOrganon Polska Sp. z o.o.
- GermanyAtorimibApontis Pharma Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Atorvacor + Ezetimib, Atozet
- Belgium · Atozet, Ezetimibe/Atorvastatin Krka
- Bulgaria · Аванор Плюс, Зетовар
- Cyprus · Amicor Plus, Atoritimb
- Czechia · Amedo Plus, Atoris Plus
- Germany · Atorimib, Atozet
- Denmark · Atozet
- Estonia · Atoritimb, Atorvastatin/Ezetimibe Teva
- Spain · Atorduo, Atorvastatina/Ezetimiba Cinfa
- Finland · Ezetimib/Atorvastatin Krka
- France · Ezetimibe / Atorvastatine Biogaran, Ezetimibe/Atorvastatine Arrow
- United Kingdom (Northern Ireland) · Atozet
- Greece · Ancilleg, Ator-Chol Plus
- Croatia · Altrexyl, Artas Plus
- Hungary · Atoris Plus, Cholezta
- Ireland · Atozet, Ezetimibe/Atorvastatin
- Iceland · Ezetimibe/Atorvastatin Stada
- Italy · Ancilleg, Athemibe
- Lithuania · Aterezim, Atorvastatin/Ezetimibe Teva
- Luxembourg · Atozet, Ezetimib/Atorvastatin Ratiopharm
- Latvia · Aterezim, Atorvastatin/Ezetimibe Teva
- Malta · Amicor Plus, Atozet
- Netherlands · Atozet, Ezeat
- Poland · Coatoris, Ezetimibe + Atorvastatin Sandoz
- Portugal · Atorduo, Atorvastatina + Ezetimiba Alter
- Romania · Co-Atoris, Coleatez
- Sweden · Atozet, Ezetimib/Atorvastatin Krka
- Slovenia · Aterezim, Ezetimib/Atorvastatin Alkaloid-Int
- Slovakia · Atoritimb, Atorvastatín/Ezetimib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e773a5ab-00ee-435d-92c7-55ea1c916416 GET /v1/drugs/e773a5ab-00ee-435d-92c7-55ea1c916416?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "ezetimibum 10 mg + atorvastatinum 10 mg",
"valid_from": "2022-05-01",
"limitations": "[{\"description\":\"Die Vergütung erfolgt bei:<br>\\n - Patienten mit hohem Risiko gemäss AGLA-Risikokategorie, die den LDL-Zielwert <1.8 mmol/l und eine LDL-Senkung um 50% mit einem hochwirksamen Statin (Atorvastatin, Rosuvastatin) in maximal verträglicher Dosis alleine nicht erreichen.<br>\\n - Patienten mit sehr hohem Risiko gemäss AGLA-Risikokategorie, die den LDL-Zielwert <1.4 mmol/l und eine LDL-Senkung um 50% mit einem hochwirksamen Statin (Atorvastatin, Rosuvastatin) in maximal verträglicher Dosis alleine nicht erreichen.<br>\\n - Patienten mit Statin-Intoleranz, d.h. Patienten, die bei Einnahme eines Statins nicht tolerierbare Muskelschmerzen und/oder messbare Muskelschwäche und/oder eine Erhöhung der Creatininkinase >5x des oberen Grenzwertes aufweisen. Vor der Verschreibung von EZETIMIB-ATORVASTATIN-MEPHA ist ein anderes Statin und, sofern dies nicht vertragen wird, Atorvastatin oder Rosuvastatin 5-10 mg 1-2x pro Woche auszuprobieren.<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-07-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 10mg/10mg",
"therapeutic_area": null,
"sl_inclusion_date": "2022-05-01",
"self_retention_pct": 10
}See everything about atorvastatin and ezetimibe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.